EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Scope & Guideline

Advancing the Frontiers of Psychiatry and Neuroscience

Introduction

Delve into the academic richness of EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0940-1334
PublisherSPRINGER HEIDELBERG
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1990 to 2024
AbbreviationEUR ARCH PSY CLIN N / Eur. Arch. Psych. Clin. Neurosci.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY

Aims and Scopes

The *European Archives of Psychiatry and Clinical Neuroscience* is dedicated to advancing the understanding of psychiatric disorders and their treatment through innovative research. The journal emphasizes empirical studies that elucidate the biological, psychological, and social dimensions of psychiatric conditions.
  1. Neurobiological Mechanisms:
    Research published focuses on the neurobiological underpinnings of psychiatric disorders, including studies on neurotransmitter systems, brain connectivity, and neuroinflammation.
  2. Clinical Interventions and Treatments:
    The journal regularly features studies evaluating the efficacy of various treatment modalities, including pharmacological, psychological, and neurostimulation interventions for mental health disorders.
  3. Transdiagnostic Approaches:
    There is a significant emphasis on transdiagnostic research that explores commonalities across different psychiatric disorders, offering insights into shared mechanisms and treatment responses.
  4. Impact of Societal Factors:
    The journal addresses how societal influences, including socioeconomic factors and public health crises like COVID-19, affect mental health outcomes and treatment accessibility.
  5. Genetic and Epigenetic Studies:
    Research often includes genetic and epigenetic analyses to identify biomarkers and understand heritable aspects of psychiatric conditions.
  6. Cognitive and Behavioral Aspects:
    Papers frequently explore cognitive functions and behavioral patterns associated with psychiatric disorders, contributing to a holistic understanding of patient experiences.
Recent publications in the journal indicate a shift toward several emerging themes that are gaining traction in psychiatric research. These trends reflect contemporary challenges in mental health and advancements in scientific inquiry.
  1. Impact of COVID-19 on Mental Health:
    There is a significant increase in studies investigating the psychological effects of the COVID-19 pandemic, including its impact on anxiety, depression, and the emergence of new psychiatric symptoms.
  2. Neurostimulation Techniques:
    Research on neurostimulation methods, such as transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT), is on the rise, highlighting their efficacy in treating treatment-resistant conditions.
  3. Biomarkers and Personalized Medicine:
    Emerging studies focusing on identifying biomarkers for psychiatric disorders are becoming prevalent, paving the way for more tailored treatment approaches.
  4. Cognitive Behavioral Interventions:
    There is a growing interest in cognitive and behavioral therapies, particularly those that integrate technology, such as mobile health applications and teletherapy.
  5. Substance Use and Mental Health Correlations:
    Research exploring the interplay between substance use (including cannabis and opioids) and psychiatric disorders is trending, reflecting societal changes and public health concerns.
  6. Transdiagnostic Research:
    An increase in transdiagnostic studies that explore shared mechanisms across various mental health disorders is evident, indicating a shift towards understanding psychiatric conditions holistically.

Declining or Waning

As the field of psychiatry evolves, certain research themes appear to be declining in prominence within the journal. These waning scopes may reflect shifting research priorities or advancements in understanding.
  1. Traditional Psychodynamic Approaches:
    There has been a noticeable decrease in publications focusing exclusively on psychodynamic theories and therapies, as empirical, evidence-based approaches gain favor.
  2. Pharmacological Monotherapy Studies:
    Research solely centered on single-drug efficacy without considering combination therapies or integrative approaches seems to be less frequent, as the field moves toward personalized medicine.
  3. Stigmatization and Mental Health Awareness:
    While still relevant, studies examining stigma related to mental health have become less central compared to empirical investigations into treatment efficacy and neurobiological mechanisms.
  4. Longitudinal Studies without Integrated Approaches:
    There appears to be a reduction in longitudinal studies that do not incorporate multidisciplinary approaches, especially those that fail to link clinical outcomes with biological or genetic data.

Similar Journals

BMC Psychiatry

Pioneering insights in psychiatry and mental wellness.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.

ACTAS ESPANOLAS DE PSIQUIATRIA

Connecting minds: Where Spanish-speaking psychiatry thrives.
Publisher: JUAN JOSE LOPEZ-IBOR FOUNDATIONISSN: 1139-9287Frequency: 6 issues/year

ACTAS ESPANOLAS DE PSIQUIATRIA, published by the renowned JUAN JOSE LOPEZ-IBOR FOUNDATION, serves as a vital resource in the field of psychiatry and mental health, particularly within the Spanish-speaking academic community. With its ISSN 1139-9287 and E-ISSN 1578-2735, this journal has been a critical platform for disseminating high-quality research since its inception in 1996 and continues to contribute valuable insights until 2024. As a recognized journal in the Q3 category of psychiatry and mental health, it ranks 387 out of 567 in Scopus, placing it within the 31st percentile, thereby indicating a growing influence among its peers. The journal’s open access options enhance its accessibility, encouraging a broader readership to engage with contemporary research issues in mental health. Researchers, professionals, and students alike will find ACTAS ESPANOLAS DE PSIQUIATRIA essential for staying informed on the latest developments and innovations in psychiatric practice and research.

Klinik Psikiyatri Dergisi-Turkish Journal of Clinical Psychiatry

Transforming Understanding of Psychological Disorders
Publisher: KLINIK PSIKIYATRI DERGISIISSN: 1302-0099Frequency: 4 issues/year

Klinik Psikiyatri Dergisi - Turkish Journal of Clinical Psychiatry is a distinguished open-access journal dedicated to the evolving field of psychiatry and mental health. Published by KLINIK PSIKIYATRI DERGISI in Turkey since 1998, this journal aims to provide a platform for the dissemination of research, clinical studies, and reviews that contribute to the understanding of psychological disorders and treatment methodologies. With an ISSN of 1302-0099 and an E-ISSN of 2146-7153, the journal is indexed in various databases, although it currently holds a rank of 460/567 in the Scopus ranking for the category of Medicine: Psychiatry and Mental Health. The journal operates under an open-access model, ensuring that research findings are readily accessible to a wide audience, contributing to greater knowledge and awareness in the field. As it converges from 2017 to 2024, Klinik Psikiyatri Dergisi continues to strive for excellence, providing valuable insights and resources for researchers, professionals, and students interested in the complexities of mental health.

PSYCHOLOGICAL MEDICINE

Advancing the frontiers of mental health research.
Publisher: CAMBRIDGE UNIV PRESSISSN: 0033-2917Frequency: 16 issues/year

PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.

General Psychiatry

Connecting researchers to reshape the future of psychiatry.
Publisher: BMJ PUBLISHING GROUPISSN: 2096-5923Frequency: 6 issues/year

General Psychiatry is a leading open-access journal published by BMJ PUBLISHING GROUP, dedicated to advancing the field of psychiatry and mental health. With an impressive impact factor and ranked in the Q1 category across various related disciplines—including Psychiatry and Mental Health, as well as Clinical Neurology—this journal offers a vital platform for researchers and practitioners in the field to disseminate high-quality studies and insights. The journal has been open access since 2018, ensuring that the latest research is freely available to a global audience, thus fostering greater collaboration and innovation. With a focus on significant developments and emerging trends, General Psychiatry serves as an essential resource for professionals keen on improving mental health practices and understanding neurological aspects of mental disorders. The journal is based in the United Kingdom, reflecting a commitment to global health discussions and initiatives in psychiatry.

American Journal of Alzheimers Disease and Other Dementias

Unlocking insights into Alzheimer's and dementia.
Publisher: SAGE PUBLICATIONS INCISSN: 1533-3175Frequency: 81 issues/year

The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.

Behavioral and Brain Functions

Exploring the Intricacies of Neuroscience
Publisher: BMCISSN: Frequency: 1 issue/year

Behavioral and Brain Functions is a leading Open Access journal published by BMC, dedicated to advancing the field of behavioral neuroscience, cognitive neuroscience, and biological psychiatry since its inception in 2005. This esteemed journal, based in the United Kingdom, has established itself as a vital resource for researchers and professionals, boasting a remarkable influence demonstrated by its Q1 and Q2 rankings across multiple relevant categories. With its commitment to providing unrestricted access to high-quality research, the journal facilitates the dissemination of significant findings in understanding the complex interactions between behavior and brain function. The journal ranks impressively within the Scopus database, positioning itself among the top-tier publications in its categories, making it an essential platform for academic discourse and innovation. As it converges through 2024, Behavioral and Brain Functions continues to play a crucial role in shaping the forefront of neuroscientific inquiry, inviting contributions that challenge our understanding and promote further exploration in these dynamic fields.

PSYCHIATRY AND CLINICAL NEUROSCIENCES

Exploring the Complexities of Mind and Brain
Publisher: WILEYISSN: 1323-1316Frequency: 12 issues/year

PSYCHIATRY AND CLINICAL NEUROSCIENCES is a leading journal in the fields of psychiatry and clinical neurology, published by Wiley. With a commendable impact factor and a position within the prestigious Q1 quartile across multiple relevant categories—including Medicine (Miscellaneous), Neurology, and Psychiatry and Mental Health—this journal stands out for its rigorous peer-reviewed content that addresses critical issues in mental health and neurological disorders. Established in 1933, the journal has a rich history of contributing impactful research that guides both clinical practice and academic inquiry. Although it is not an open-access journal, its high relevance is underscored by its Scopus rankings, with notable percentiles in Psychiatry and Neurology, making it a vital resource for researchers, clinicians, and students looking to stay abreast of the latest advancements. Located in the United Kingdom, PSYCHIATRY AND CLINICAL NEUROSCIENCES aims to bridge the gap between theory and practical application, fostering a comprehensive understanding of the complex interplay between mental health and neurological conditions.

Neuropsychopharmacology Reports

Pioneering discoveries in the field of neuropsychopharmacology.
Publisher: WILEYISSN: Frequency: 4 issues/year

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

NEUROPSYCHOBIOLOGY

Decoding Behavior: Insights from Neuropsychobiology
Publisher: KARGERISSN: 0302-282XFrequency: 6 issues/year

NEUROPSYCHOBIOLOGY, published by KARGER, is a leading academic journal that has been at the forefront of exploring the intricate relationships between neuroscience and psychological processes since its inception in 1975. With both an ISSN of 0302-282X and an E-ISSN of 1423-0224, the journal is renowned for its rigorous peer-reviewed articles and significant contributions to the fields of Biological Psychiatry, Neuropsychology, and Physiological Psychology. Its impact is reflected in its esteemed Scopus rankings, standing out in the 92nd and 81st percentiles in their respective categories. With a commitment to advancing understanding in mental health and neurological science, NEUROPSYCHOBIOLOGY is classified in the Q3 and Q1 quartiles, making it a vital resource for researchers, clinicians, and students alike. Based in Switzerland, the journal embraces a holistic approach to psychological research, bridging gaps between theoretical frameworks and practical applications, thus promoting impactful advancements in the understanding of the human mind.
Explore the latest findings and theories with NEUROPSYCHOBIOLOGY, where your work can contribute to the evolving landscape of neuropsychological studies.